Foundation Fighting Blindness

First-of-its-kind small molecule therapy targets protein misfolding at the root of RHO-adRP

First patient shows vision improvements with a good safety profile.

To celebrate episode 100 of Eye on the Cure, host Ben Shaberman features highlights from conversations with some of his previous guests including: Dr. Dean Bok from UCLA, Dr. Michel Michaelides from Moorfields Eye Hospital, actor Ben Mehl, triathlete Michael Stone, and jazz keyboardist Matthew Whitaker. This "Best Of" episode is Ben's final for Eye on the Cure, but the podcast will continue on with a new host. Stay tuned!

Novel neuroprotective approach could benefit RP patients regardless of genetic mutation

Listen to the latest episode of the Blind & Beyond radio show featuring Foundation Fighting Blindness CEO Jason Menzo. Jason discusses the Foundation's mission and the remarkable progress achieved over the past 55 years in advancing diagnostics, treatments, and cures for blinding diseases. He also shares insights into ongoing advocacy efforts on Capitol Hill to preserve critical vision research funding through the FDA and National Eye Institute. The conversation concludes with an invitation for listeners to register for VISIONS 2026, the Foundation's global conference taking place June 12–13 in Fort Worth, Texas.